Ionis Pharmaceuticals
IONS
IONS
336 hedge funds and large institutions have $4.92B invested in Ionis Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 114 increasing their positions, 107 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
336
Holders Change
-9
Holders Change %
-2.61%
% of All Funds
5.42%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
50
Increased
114
Reduced
107
Closed
52
Calls
$15.2M
Puts
$12.8M
Net Calls
+$2.47M
Net Calls Change
-$7.76M
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$46.3M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$45.5M |
| 3 |
TBC
Tweedy, Browne Co
Stamford,
Connecticut
|
+$30.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$24.8M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$66.1M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$39.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$19.1M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$18M |
| 5 |
Goldman Sachs
New York
|
-$13.9M |
